Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 10, 2004, Pages 1133-1134

  Matucci, A ^a   Parronchi, P ^b   Vultaggio, A ^b   Rossi, O ^b   Brugnolo, F ^b   Maggi, E ^b   Romagnani, S ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

Cyclo oxygenase; Drug allergy; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SIDE EFFECT; SKIN MANIFESTATION; URTICARIA;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS REACTIONS; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LACTONES; MALE; MIDDLE AGED; SULFONES; TREATMENT OUTCOME;

EID: 4644245794     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00532.x     Document Type: Article

References (5)

1. GRUCHALLA RS. Drug allergy. J Allergy Clin Immunol 2003;111:S548-S559.
2. DEMOLY P, JAFFUEL D, LEQUEUX N, WEKSLER B, CREMINON C, MICHEL FB, et al. Prostaglandin H synthase I and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Resp Crit Care Med 1997;155:670-675.
3. FITZGERALD GA, PATRONO C. The coxib, selective inhibitors of cyclooxygenase-2. New Engl J Med 2001;345:433-442.
4. KOSNIK M, MUSIC E, MATJAZ F, SUSKOVIC S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998;53:1231-1233.
5. SCHWAB JM, SCHLUESENER HJ, LAUFER S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet 2003;361:981-982.